Advanced Oncotherapy PLC Video and update on progress at Harley Street

TIDMAVO

Advanced Oncotherapy PLC

05 July 2017

ADVANCED ONCOTHERAPY PLC

("Advanced Oncotherapy" or the "Company")

Video and update on progress at Harley Street

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the release of a short video providing an update on the facility at Harley Street and progress made on site. The video features Deconstruct (UK) Limited, principal contractor to the project, and highlights its role in the demolition, excavation and rebuild at 141/143 Harley Street.

Mick Durie, a director of Deconstruct, provides a breakdown of the step-by-step process of the building project, the key objectives and Deconstruct's expertise and experience in working on comparable builds.

The video can be viewed at http://www.avoplc.com/

The Company also confirms that work has progressed considerably since the filming of the video; piling, which will form the foundations for construction at 141/143 Harley Street and per the announcement of 30 May 2017, has commenced.

Commenting, Nicolas Serandour, CEO of Advanced Oncotherapy said: "This video and the progress made to be able to begin piling clearly show how far we've come in developing the site at Harley Street. The extent of the work done so far is clear, we are confident of delivering within the timescales we provided and are grateful for the support provided by The Howard de Walden Estate. Deconstruct are a highly experienced firm and we have every confidence they will meet our expectations in completing the rebuild on schedule."

For further information, please contact:

 
 Advanced Oncotherapy                    www.avoplc.com 
  Plc 
 Dr. Michael Sinclair,            Tel: [phone] 
  Executive Chairman 
 Nicolas Serandour, CEO 
 
 Stockdale Securities 
  (Nomad & Joint Broker) 
 Antonio Bossi / David            Tel: [phone] 
  Coaten 
 
 Stifel Nicolaus Europe 
  (Joint Broker) 
 Jonathan Senior / Ben            Tel: [phone] 
  Maddison 
 
 Walbrook PR (Financial        Tel: [phone] or 
  PR & IR)                           [e-mail] 
 Paul McManus / Anna       Mob: [phone] / Mob: 
  Dunphy                               [phone] 
 

About Advanced Oncotherapy plc www.avoplc.com

Advanced Oncotherapy is a provider of particle therapy with protons that harnesses the best in modern technology. Advanced Oncotherapy's team "ADAM", based in Geneva, focuses on the development of a proprietary proton accelerator called Linac Image Guided Hadron Technology (LIGHT). LIGHT accelerates protons to the energy levels achieved in legacy machines but in a unit that is a quarter of the size and between a quarter and a fifth of the cost. This compact configuration delivers proton beams in a way that facilitates greater precision and electronic control which is not achievable with older technologies.

Advanced Oncotherapy will offer healthcare providers affordable systems that will enable them to treat cancer with an innovative technology as well as better health outcomes and lower treatment related side effects.

Advanced Oncotherapy continually monitors the market for any emerging improvements in delivering proton therapy and actively seeks working relationships with providers of these innovative technologies. Through these relationships, the Company will remain the prime provider of an innovative and cost-effective system for particle therapy with protons.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRALZLFBDDFXBBQ

(END) Dow Jones Newswires

July 05, 2017 02:00 ET (06:00 GMT)